25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

RepliCel Life Sciences Inc
Buy, Hold or Sell?

Let's analyze Replicel together

I guess you are interested in RepliCel Life Sciences Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of RepliCel Life Sciences Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about RepliCel Life Sciences Inc

I send you an email if I find something interesting about RepliCel Life Sciences Inc.

1. Quick Overview

1.1. Quick analysis of Replicel (30 sec.)










1.2. What can you expect buying and holding a share of Replicel? (30 sec.)

How much money do you get?

How much money do you get?
C$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
C$-0.07
Expected worth in 1 year
C$0.02
How sure are you?
40.0%

+ What do you gain per year?

Total Gains per Share
C$0.09
Return On Investment
851.9%

For what price can you sell your share?

Current Price per Share
C$0.01
Expected price per share
C$0 - C$0.05
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Replicel (5 min.)




Live pricePrice per Share (EOD)
C$0.01
Intrinsic Value Per Share
C$-0.43 - C$-0.36
Total Value Per Share
C$-0.50 - C$-0.43

2.2. Growth of Replicel (5 min.)




Is Replicel growing?

Current yearPrevious yearGrowGrow %
How rich?-$3.2m-$4.2m$992.3k30.6%

How much money is Replicel making?

Current yearPrevious yearGrowGrow %
Making money-$223.4k-$532.7k$309.2k138.4%
Net Profit Margin-88.1%-210.1%--

How much money comes from the company's main activities?

2.3. Financial Health of Replicel (5 min.)




2.4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#865 / 958

Most Revenue
#701 / 958

Most Profit
#152 / 958
3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Replicel?

Welcome investor! Replicel's management wants to use your money to grow the business. In return you get a share of Replicel.

First you should know what it really means to hold a share of Replicel. And how you can make/lose money.

Speculation

The Price per Share of Replicel is C$0.01. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Replicel.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Replicel, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is C$-0.07. Based on the TTM, the Book Value Change Per Share is C$0.02 per quarter. Based on the YOY, the Book Value Change Per Share is C$0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is C$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Replicel.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 C$% of Price per ShareC$% of Price per ShareC$% of Price per ShareC$% of Price per ShareC$% of Price per Share
Usd Eps0.00-34.4%0.00-34.4%-0.01-82.0%-0.02-214.2%-0.04-364.2%
Usd Book Value Change Per Share0.02152.7%0.02152.7%0.01102.2%-0.01-89.9%-0.01-66.2%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share0.02152.7%0.02152.7%0.01102.2%-0.01-89.9%-0.01-66.2%
Usd Price Per Share0.05-0.05-0.06-0.12-0.23-
Price to Earnings Ratio-13.55--13.55--7.43--7.93--7.50-
Price-to-Total Gains Ratio3.05-3.05-5.96--5.42--12.22-
Price to Book Ratio-0.93--0.93--0.93--2.15--10.79-
Price-to-Total Gains Ratio3.05-3.05-5.96--5.42--12.22-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.007168
Number of shares139508
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share0.02-0.01
Usd Total Gains Per Share0.02-0.01
Gains per Quarter (139508 shares)2,129.75-1,254.02
Gains per Year (139508 shares)8,518.99-5,016.09
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10851985090-5016-5026
2017038170280-10032-10042
3025557255470-15048-15058
4034076340660-20064-20074
5042595425850-25080-25090
6051114511040-30097-30106
7059633596230-35113-35122
8068152681420-40129-40138
9076671766610-45145-45154
10085190851800-50161-50170

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%1.020.00.04.8%
Book Value Change Per Share1.00.00.0100.0%2.01.00.066.7%2.03.00.040.0%4.06.00.040.0%9.012.00.042.9%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.010.00.0%0.00.021.00.0%
Total Gains per Share1.00.00.0100.0%2.01.00.066.7%2.03.00.040.0%4.06.00.040.0%9.012.00.042.9%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of RepliCel Life Sciences Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0210.0210%0.014+49%-0.013+159%-0.009+143%
Book Value Per Share---0.070-0.0700%-0.091+31%-0.082+18%-0.039-45%
Current Ratio--0.0890.0890%0.307-71%0.173-49%1.323-93%
Debt To Asset Ratio--16.74416.7440%8.411+99%12.099+38%6.596+154%
Debt To Equity Ratio----0%-0%-0%0.070-100%
Dividend Per Share----0%-0%-0%-0%
Eps---0.005-0.0050%-0.011+138%-0.030+523%-0.051+959%
Free Cash Flow Per Share---0.022-0.0220%-0.0220%-0.027+26%-0.042+91%
Free Cash Flow To Equity Per Share---0.005-0.0050%0.003-284%-0.007+32%-0.003-47%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---0.364--------
Intrinsic Value_10Y_min---0.429--------
Intrinsic Value_1Y_max---0.029--------
Intrinsic Value_1Y_min---0.042--------
Intrinsic Value_3Y_max---0.094--------
Intrinsic Value_3Y_min---0.129--------
Intrinsic Value_5Y_max---0.165--------
Intrinsic Value_5Y_min---0.216--------
Market Cap650016.000-550%4225104.0004225104.0000%5525136.000-24%11245276.800-62%20865513.600-80%
Net Profit Margin---0.881-0.8810%-2.101+138%-5.492+523%-5.032+471%
Operating Margin---3.919-3.9190%-0.541-86%-4.962+27%-4.718+20%
Operating Ratio--4.9194.9190%4.9370%6.277-22%5.500-11%
Pb Ratio-0.143+85%-0.933-0.9330%-0.934+0%-2.150+131%-10.788+1057%
Pe Ratio-2.085+85%-13.554-13.5540%-7.434-45%-7.927-42%-7.497-45%
Price Per Share0.010-550%0.0650.0650%0.085-24%0.173-62%0.321-80%
Price To Free Cash Flow Ratio-0.460+85%-2.988-2.9880%-3.920+31%-7.670+157%-13.209+342%
Price To Total Gains Ratio0.470-550%3.0523.0520%5.959-49%-5.418+278%-12.223+500%
Quick Ratio--0.0720.0720%0.256-72%0.132-45%1.858-96%
Return On Assets---1.083-1.0830%-0.931-14%-3.719+243%-4.345+301%
Return On Equity----0%-0%-0%-0.6420%
Total Gains Per Share--0.0210.0210%0.014+49%-0.013+159%-0.009+143%
Usd Book Value---3247736.218-3247736.2180%-4240059.085+31%-3838546.432+18%-1802025.595-45%
Usd Book Value Change Per Share--0.0150.0150%0.010+49%-0.009+159%-0.007+143%
Usd Book Value Per Share---0.050-0.0500%-0.065+31%-0.059+18%-0.028-45%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.003-0.0030%-0.008+138%-0.021+523%-0.036+959%
Usd Free Cash Flow---1013614.694-1013614.6940%-1010295.9100%-1273673.462+26%-1936801.413+91%
Usd Free Cash Flow Per Share---0.016-0.0160%-0.0160%-0.020+26%-0.030+91%
Usd Free Cash Flow To Equity Per Share---0.004-0.0040%0.002-284%-0.005+32%-0.002-47%
Usd Market Cap465931.469-550%3028554.5473028554.5470%3960417.485-24%8060614.410-62%14956400.148-80%
Usd Price Per Share0.007-550%0.0470.0470%0.061-24%0.124-62%0.230-80%
Usd Profit---223450.931-223450.9310%-532745.830+138%-1392415.683+523%-2366146.048+959%
Usd Revenue--253557.248253557.2480%253557.2480%253557.2480%135460.076+87%
Usd Total Gains Per Share--0.0150.0150%0.010+49%-0.009+159%-0.007+143%
 EOD+1 -7MRQTTM+0 -0YOY+14 -165Y+22 -810Y+19 -13

3.3 Fundamental Score

Let's check the fundamental score of RepliCel Life Sciences Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-2.085
Price to Book Ratio (EOD)Between0-1-0.143
Net Profit Margin (MRQ)Greater than0-0.881
Operating Margin (MRQ)Greater than0-3.919
Quick Ratio (MRQ)Greater than10.072
Current Ratio (MRQ)Greater than10.089
Debt to Asset Ratio (MRQ)Less than116.744
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-1.083
Total1/10 (10.0%)

3.4 Technical Score

Let's check the technical score of RepliCel Life Sciences Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than500.001
Ma 20Greater thanMa 500.044
Ma 50Greater thanMa 1000.051
Ma 100Greater thanMa 2000.053
OpenGreater thanClose0.015
Total1/5 (20.0%)

4. In-depth Analysis

4.1 About RepliCel Life Sciences Inc

RepliCel Life Sciences Inc., a regenerative medicine company, focuses on developing autologous cell therapies that treat functional cellular deficits. Its treatments use autologous cell therapy to treat tendon injuries, androgenetic alopecia, and skin aging by restoring cellular function to rejuvenate aging or sun damaged skin, regrow hair, and repair tendons. The company's product candidates include RCH-01, a cell therapy for pattern baldness; RCS-01, a cell therapy foraging or sun damaged skin; and RCT-01, a cell therapy for tendon degeneration. It is also developing DermaPrecise, a dermal injection device. The company has a licensing and collaborative agreement with YOFOTO (China) Health Industry Co. Ltd. to develop and commercialize RCS-01, RCT-01, and DermaPrecise. RepliCel Life Sciences Inc. is based in Vancouver, Canada.

Fundamental data was last updated by Penke on 2024-10-16 15:41:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Replicel earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Replicel to the Biotechnology industry mean.
  • A Net Profit Margin of -88.1% means that $-0.88 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of RepliCel Life Sciences Inc:

  • The MRQ is -88.1%. The company is making a huge loss. -2
  • The TTM is -88.1%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-88.1%TTM-88.1%0.0%
TTM-88.1%YOY-210.1%+122.0%
TTM-88.1%5Y-549.2%+461.0%
5Y-549.2%10Y-503.2%-45.9%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-88.1%-135.4%+47.3%
TTM-88.1%-201.5%+113.4%
YOY-210.1%-209.8%-0.3%
5Y-549.2%-359.0%-190.2%
10Y-503.2%-472.9%-30.3%
4.3.1.2. Return on Assets

Shows how efficient Replicel is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Replicel to the Biotechnology industry mean.
  • -108.3% Return on Assets means that Replicel generated $-1.08 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of RepliCel Life Sciences Inc:

  • The MRQ is -108.3%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -108.3%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-108.3%TTM-108.3%0.0%
TTM-108.3%YOY-93.1%-15.2%
TTM-108.3%5Y-371.9%+263.6%
5Y-371.9%10Y-434.5%+62.6%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-108.3%-10.7%-97.6%
TTM-108.3%-11.7%-96.6%
YOY-93.1%-11.2%-81.9%
5Y-371.9%-12.6%-359.3%
10Y-434.5%-14.2%-420.3%
4.3.1.3. Return on Equity

Shows how efficient Replicel is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Replicel to the Biotechnology industry mean.
  • 0.0% Return on Equity means Replicel generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of RepliCel Life Sciences Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-64.2%+64.2%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--13.8%+13.8%
TTM--16.0%+16.0%
YOY--13.6%+13.6%
5Y--18.5%+18.5%
10Y-64.2%-19.0%-45.2%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of RepliCel Life Sciences Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Replicel is operating .

  • Measures how much profit Replicel makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Replicel to the Biotechnology industry mean.
  • An Operating Margin of -391.9% means the company generated $-3.92  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of RepliCel Life Sciences Inc:

  • The MRQ is -391.9%. The company is operating very inefficient. -2
  • The TTM is -391.9%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-391.9%TTM-391.9%0.0%
TTM-391.9%YOY-54.1%-337.8%
TTM-391.9%5Y-496.2%+104.3%
5Y-496.2%10Y-471.8%-24.4%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-391.9%-289.1%-102.8%
TTM-391.9%-313.4%-78.5%
YOY-54.1%-223.5%+169.4%
5Y-496.2%-386.0%-110.2%
10Y-471.8%-497.4%+25.6%
4.3.2.2. Operating Ratio

Measures how efficient Replicel is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 4.92 means that the operating costs are $4.92 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of RepliCel Life Sciences Inc:

  • The MRQ is 4.919. The company is inefficient in keeping operating costs low. -1
  • The TTM is 4.919. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ4.919TTM4.9190.000
TTM4.919YOY4.937-0.018
TTM4.9195Y6.277-1.358
5Y6.27710Y5.500+0.777
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ4.9192.821+2.098
TTM4.9193.146+1.773
YOY4.9373.336+1.601
5Y6.2774.839+1.438
10Y5.5006.520-1.020
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of RepliCel Life Sciences Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Replicel is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 0.09 means the company has $0.09 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of RepliCel Life Sciences Inc:

  • The MRQ is 0.089. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.089. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.089TTM0.0890.000
TTM0.089YOY0.307-0.218
TTM0.0895Y0.173-0.084
5Y0.17310Y1.323-1.150
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0893.740-3.651
TTM0.0893.923-3.834
YOY0.3074.711-4.404
5Y0.1735.957-5.784
10Y1.3236.285-4.962
4.4.3.2. Quick Ratio

Measures if Replicel is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Replicel to the Biotechnology industry mean.
  • A Quick Ratio of 0.07 means the company can pay off $0.07 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of RepliCel Life Sciences Inc:

  • The MRQ is 0.072. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.072. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.072TTM0.0720.000
TTM0.072YOY0.256-0.183
TTM0.0725Y0.132-0.060
5Y0.13210Y1.858-1.726
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0723.326-3.254
TTM0.0723.510-3.438
YOY0.2564.633-4.377
5Y0.1325.927-5.795
10Y1.8586.479-4.621
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of RepliCel Life Sciences Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Replicel assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Replicel to Biotechnology industry mean.
  • A Debt to Asset Ratio of 16.74 means that Replicel assets are financed with 1,674.4% credit (debt) and the remaining percentage (100% - 1,674.4%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of RepliCel Life Sciences Inc:

  • The MRQ is 16.744. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 16.744. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ16.744TTM16.7440.000
TTM16.744YOY8.411+8.333
TTM16.7445Y12.099+4.645
5Y12.09910Y6.596+5.503
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ16.7440.339+16.405
TTM16.7440.347+16.397
YOY8.4110.310+8.101
5Y12.0990.365+11.734
10Y6.5960.381+6.215
4.5.4.2. Debt to Equity Ratio

Measures if Replicel is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Replicel to the Biotechnology industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of RepliCel Life Sciences Inc:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y0.070-0.070
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.393-0.393
TTM-0.444-0.444
YOY-0.375-0.375
5Y-0.450-0.450
10Y0.0700.489-0.419
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Replicel generates.

  • Above 15 is considered overpriced but always compare Replicel to the Biotechnology industry mean.
  • A PE ratio of -13.55 means the investor is paying $-13.55 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of RepliCel Life Sciences Inc:

  • The EOD is -2.085. Based on the earnings, the company is expensive. -2
  • The MRQ is -13.554. Based on the earnings, the company is expensive. -2
  • The TTM is -13.554. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.085MRQ-13.554+11.468
MRQ-13.554TTM-13.5540.000
TTM-13.554YOY-7.434-6.120
TTM-13.5545Y-7.927-5.626
5Y-7.92710Y-7.497-0.430
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-2.085-2.472+0.387
MRQ-13.554-2.481-11.073
TTM-13.554-2.977-10.577
YOY-7.434-3.435-3.999
5Y-7.927-5.847-2.080
10Y-7.497-6.262-1.235
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of RepliCel Life Sciences Inc:

  • The EOD is -0.460. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -2.988. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -2.988. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.460MRQ-2.988+2.528
MRQ-2.988TTM-2.9880.000
TTM-2.988YOY-3.920+0.932
TTM-2.9885Y-7.670+4.682
5Y-7.67010Y-13.209+5.539
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.460-3.231+2.771
MRQ-2.988-3.261+0.273
TTM-2.988-3.497+0.509
YOY-3.920-4.550+0.630
5Y-7.670-7.975+0.305
10Y-13.209-8.686-4.523
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Replicel is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of -0.93 means the investor is paying $-0.93 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of RepliCel Life Sciences Inc:

  • The EOD is -0.143. Based on the equity, the company is expensive. -2
  • The MRQ is -0.933. Based on the equity, the company is expensive. -2
  • The TTM is -0.933. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.143MRQ-0.933+0.789
MRQ-0.933TTM-0.9330.000
TTM-0.933YOY-0.934+0.002
TTM-0.9335Y-2.150+1.218
5Y-2.15010Y-10.788+8.638
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-0.1431.996-2.139
MRQ-0.9331.985-2.918
TTM-0.9332.191-3.124
YOY-0.9342.387-3.321
5Y-2.1503.580-5.730
10Y-10.7884.199-14.987
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2023-12-31. All numbers in thousands.

Summary
Total Assets288
Total Liabilities4,819
Total Stockholder Equity-4,531
 As reported
Total Liabilities 4,819
Total Stockholder Equity+ -4,531
Total Assets = 288

Assets

Total Assets288
Total Current Assets162
Long-term Assets126
Total Current Assets
Cash And Cash Equivalents 59
Short-term Investments 17
Net Receivables 38
Other Current Assets 48
Total Current Assets  (as reported)162
Total Current Assets  (calculated)162
+/-0
Long-term Assets
Property Plant Equipment 1
Other Assets 0
Long-term Assets  (as reported)126
Long-term Assets  (calculated)1
+/- 125

Liabilities & Shareholders' Equity

Total Current Liabilities1,822
Long-term Liabilities2,996
Total Stockholder Equity-4,531
Total Current Liabilities
Short-term Debt 813
Accounts payable 416
Other Current Liabilities 239
Total Current Liabilities  (as reported)1,822
Total Current Liabilities  (calculated)1,469
+/- 354
Long-term Liabilities
Long-term Liabilities  (as reported)2,996
Long-term Liabilities  (calculated)0
+/- 2,996
Total Stockholder Equity
Common Stock33,116
Retained Earnings -43,287
Other Stockholders Equity 5,640
Total Stockholder Equity (as reported)-4,531
Total Stockholder Equity (calculated)-4,531
+/-0
Other
Cash and Short Term Investments 76
Common Stock Shares Outstanding 59,242
Current Deferred Revenue354
Liabilities and Stockholders Equity 288
Net Debt 754
Net Working Capital -1,660
Short Long Term Debt Total 813



6.2. Balance Sheets Structured

All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-31
> Total Assets 
18
3,435
3,246
307
36
57
91
1,309
631
505
2,052
2,141
416
1,828
846
3,227
505
421
592
798
288
2887985924215053,2278461,8284162,1412,0525056311,3099157363073,2463,43518
   > Total Current Assets 
5
138
5
130
15
35
91
1,276
613
484
2,029
2,115
395
1,813
835
3,004
233
186
393
636
162
1626363931862333,0048351,8133952,1152,0294846131,27691351513051385
       Cash And Cash Equivalents 
3
85
4
121
5
30
90
1,212
565
384
1,958
535
176
61
497
2,419
24
34
221
413
59
5941322134242,419497611765351,9583845651,212903051214853
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
1,500
0
1,450
0
0
29
17
17
17
17
1717171729001,45001,50000000000000
       Net Receivables 
2
34
2
10
11
4
1
41
27
48
25
29
26
66
49
75
52
64
61
82
38
38826164527549662629254827411411102342
       Other Current Assets 
0
19
0
0
0
0
0
0
0
0
0
0
193
236
289
25
129
70
93
123
48
481239370129252892361930000000000190
   > Long-term Assets 
13
3,297
3,241
177
20
23
0
33
19
22
23
26
21
15
11
223
272
235
199
163
126
1261631992352722231115212623221933023201773,2413,29713
       Property Plant Equipment 
13
329
318
177
20
23
0
33
19
22
23
26
21
15
11
8
6
4
3
2
1
12346811152126232219330232017731832913
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
1,295
0
1,081
0
0
0
0
0
0
0
00000001,08101,29500000000000
       Other Assets 
0
0
0
0
0
0
0
0
0
0
0
44
139
176
231
302
266
231
195
0
0
001952312663022311761394400000000000
> Total Liabilities 
107
2,981
3,221
136
135
328
282
623
230
484
578
335
1,018
622
1,166
3,683
4,931
5,482
7,434
6,713
4,819
4,8196,7137,4345,4824,9313,6831,1666221,0183355784842306232823281351363,2212,981107
   > Total Current Liabilities 
107
52
91
136
135
328
282
623
230
416
369
331
1,018
622
1,166
1,530
1,551
2,239
1,674
2,073
1,822
1,8222,0731,6742,2391,5511,5301,1666221,0183313694162306232823281351369152107
       Short-term Debt 
51
44
0
70
62
77
66
75
0
0
0
0
0
0
0
-551
449
47
611
689
813
81368961147449-5510000000756677627004451
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
47
0
0
0
0004700000000000000000
       Accounts payable 
56
8
91
66
73
196
194
0
0
0
342
322
802
374
856
551
640
1,320
602
818
416
4168186021,320640551856374802322342000194196736691856
       Other Current Liabilities 
0
0
0
0
0
55
22
548
0
0
0
0
1,018
622
1,166
1,278
107
518
107
212
239
2392121075181071,2781,1666221,0180000548225500000
   > Long-term Liabilities 
0
2,929
3,130
0
0
0
0
0
0
68
208
4
0
0
0
2,152
3,381
3,243
5,760
4,641
2,996
2,9964,6415,7603,2433,3812,1520004208680000003,1302,9290
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
208
4
0
0
0
3,593
3,381
3,214
5,726
0
0
005,7263,2143,3813,59300042080000000000
> Total Stockholder Equity
-90
454
25
171
-99
-270
-191
358
401
21
1,475
1,806
-602
1,206
-320
-455
-4,426
-5,061
-6,842
-5,915
-4,531
-4,531-5,915-6,842-5,061-4,426-455-3201,206-6021,8061,47521401358-191-270-9917125454-90
   Common Stock
6,815
7,461
8,065
8,514
8,802
0
0
2,312
0
0
9,431
14,047
16,499
21,910
26,182
28,746
27,530
28,471
30,291
31,661
33,116
33,11631,66130,29128,47127,53028,74626,18221,91016,49914,0479,431002,312008,8028,5148,0657,4616,815
   Retained Earnings -43,287-42,975-42,232-38,158-36,578-33,559-30,790-24,776-20,504-15,460-10,262-10,233-6,870-2,084-9,255-9,335-9,138-8,566-8,261-7,858-6,907
   Capital Surplus 000000000000000000000
   Treasury Stock000000000000000000000
   Other Stockholders Equity 
2
157
221
223
237
9,064
9,064
130
7,272
10,255
11,737
17,267
3,404
4,072
4,288
4,358
4,623
4,626
5,098
5,399
5,640
5,6405,3995,0984,6264,6234,3584,2884,0723,40417,26711,73710,2557,2721309,0649,0642372232211572



6.3. Balance Sheets

All numbers in thousands.




6.4. Cash Flows

Currency in CAD. All numbers in thousands.




6.5. Income Statements

Currency in CAD. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. All numbers in thousands.

Gross Profit (+$)
totalRevenue354
Cost of Revenue-1
Gross Profit352352
 
Operating Income (+$)
Gross Profit352
Operating Expense-1,739
Operating Income-1,386-1,386
 
Operating Expense (+$)
Research Development526
Selling General Administrative1,211
Selling And Marketing Expenses0
Operating Expense1,7391,738
 
Net Interest Income (+$)
Interest Income1
Interest Expense-149
Other Finance Cost-147
Net Interest Income-1
 
Pretax Income (+$)
Operating Income-1,386
Net Interest Income-1
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-312-2,461
EBIT - interestExpense = -1,535
-312
-163
Interest Expense149
Earnings Before Interest and Taxes (EBIT)-1,386-163
Earnings Before Interest and Taxes (EBITDA)-1,385
 
After tax Income (+$)
Income Before Tax-312
Tax Provision-0
Net Income From Continuing Ops-69-312
Net Income-312
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses1,740
Total Other Income/Expenses Net1,0751
 

Technical Analysis of Replicel
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Replicel. The general trend of Replicel is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Replicel's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of RepliCel Life Sciences Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 0.04 < 0.05 < 0.05.

The bearish price targets are: .

Tweet this
RepliCel Life Sciences Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of RepliCel Life Sciences Inc. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

RepliCel Life Sciences Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of RepliCel Life Sciences Inc. The current macd is -0.01050946.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Replicel price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Replicel. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Replicel price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
RepliCel Life Sciences Inc Daily Moving Average Convergence/Divergence (MACD) ChartRepliCel Life Sciences Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of RepliCel Life Sciences Inc. The current adx is 44.06.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Replicel shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
RepliCel Life Sciences Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of RepliCel Life Sciences Inc. The current sar is 0.0440957.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
RepliCel Life Sciences Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of RepliCel Life Sciences Inc. The current rsi is 0.00055617. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 1/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
RepliCel Life Sciences Inc Daily Relative Strength Index (RSI) ChartRepliCel Life Sciences Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of RepliCel Life Sciences Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Replicel price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
RepliCel Life Sciences Inc Daily Stochastic Oscillator ChartRepliCel Life Sciences Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of RepliCel Life Sciences Inc. The current cci is -138.82863341.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
RepliCel Life Sciences Inc Daily Commodity Channel Index (CCI) ChartRepliCel Life Sciences Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of RepliCel Life Sciences Inc. The current cmo is -99.99999925.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
RepliCel Life Sciences Inc Daily Chande Momentum Oscillator (CMO) ChartRepliCel Life Sciences Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of RepliCel Life Sciences Inc. The current willr is -100.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
RepliCel Life Sciences Inc Daily Williams %R ChartRepliCel Life Sciences Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of RepliCel Life Sciences Inc.

RepliCel Life Sciences Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of RepliCel Life Sciences Inc. The current atr is 0.00381125.

RepliCel Life Sciences Inc Daily Average True Range (ATR) ChartRepliCel Life Sciences Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of RepliCel Life Sciences Inc. The current obv is -508,255.

RepliCel Life Sciences Inc Daily On-Balance Volume (OBV) ChartRepliCel Life Sciences Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of RepliCel Life Sciences Inc. The current mfi is 0.77615368.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
RepliCel Life Sciences Inc Daily Money Flow Index (MFI) ChartRepliCel Life Sciences Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for RepliCel Life Sciences Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-06-14SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-10-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-24ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-25STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-31ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).

6.3. Candlestick Patterns

RepliCel Life Sciences Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of RepliCel Life Sciences Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than500.001
Ma 20Greater thanMa 500.044
Ma 50Greater thanMa 1000.051
Ma 100Greater thanMa 2000.053
OpenGreater thanClose0.015
Total1/5 (20.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Replicel with someone you think should read this too:
  • Are you bullish or bearish on Replicel? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Replicel? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about RepliCel Life Sciences Inc

I send you an email if I find something interesting about RepliCel Life Sciences Inc.


Comments

How you think about this?

Leave a comment

Stay informed about RepliCel Life Sciences Inc.

Receive notifications about RepliCel Life Sciences Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.